Clinical Drug Experience Knowledgebase

autologous hematopoietic stem cells (3 trials)

bleomycin (blenoxane) (1 trial)

carmustine (bicnu) (1 trial)

cyclophosphamide (cytoxan) (4 trials)

cytarabine (cytosar-u) (2 trials)

doxorubicin (Doxil) (2 trials)

etoposide (vepesid) (2 trials)

interferon alpha-2b (Intron-A) (1 trial)

melphalan (alkeran) (2 trials)

prednisone (meticorten) (3 trials)

procarbazine (matulane) (1 trial)

rituximab (rituxan) (5 trials)

sargramostim (leukine) (1 trial)

urea (2 trials)

vincristine (oncovin) (2 trials)

atezolizumab (Tecentriq) (1 trial)

bendamustine (treanda) (2 trials)

bortezomib (velcade) (1 trial)

cisplatin (platinol) (1 trial)

dexamethasone (1 trial)

fludarabine (fludara) (1 trial)

gemcitabine (gemzar) (1 trial)

lenalidomide (revlimid) (2 trials)

palonosetron (aloxi) (1 trial)

polatuzumab vedotin (Polivy) (1 trial)

thalidomide (Thalomid) (1 trial)

tislelizumab (1 trial)

vinorelbine (navelbine) (1 trial)